Since cIAP is required for TNF-dependent NF-κB signaling [36], we hypothesized that the growth advantage of MPN cells exposed to TNF could be mediated through an increase in cIAP protein levels. The gene discussed is TNF; the disease is myeloproliferative neoplasm.